Skip to main content
Clinical Trials/IRCT20230315057731N1
IRCT20230315057731N1
Recruiting
Phase 3

Survey the effect of resveratrol supplementation on some oxidative stress and inflammatory biomarkers, fatigue scale, fasting blood sugar and lipid profile in patients with Multiple Sclerosis.

Ahvaz University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Multiple Sclerosis.
Sponsor
Ahvaz University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • The disease is diagnosed according to McDonald's criteria.
  • EDSS score 0 to 5
  • The clinical condition of the patient is relapse\-remittance.
  • Age 18 to 65 years

Exclusion Criteria

  • The patient consumes alcohol, tobacco or drugs.
  • Use of antioxidant supplements and hormonal treatments.
  • Body mass index(BMI) higher than 30\.
  • Any progressive or autoimmune diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials